John George Petrovich
Vorsitzender bei Medallion Therapeutics, Inc.
Profil
John George Petrovich is currently the Chairman at Medallion Therapeutics, Inc. He previously worked as the President and CEO of Calando & Insert at Arrowhead Pharmaceuticals, Inc. from 2000 to 2007.
He also served as the CEO of Insert Therapeutics, Inc. and as the President and CEO of The Alfred E.
Mann Foundation For Scientific Research.
Additionally, he was an Independent Director at Axonics, Inc. from 2013 to 2019.
Mr. Petrovich received his undergraduate degree from the University of Southern California and his graduate degree from the University of California, Los Angeles.
Aktive Positionen von John George Petrovich
| Unternehmen | Position | Beginn |
|---|---|---|
| Medallion Therapeutics, Inc. | Vorsitzender | 01.07.2017 |
Ehemalige bekannte Positionen von John George Petrovich
| Unternehmen | Position | Ende |
|---|---|---|
| AXONICS, INC. | Direktor/Vorstandsmitglied | 04.03.2019 |
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31.10.2007 |
Insert Therapeutics, Inc.
 Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Insert Therapeutics, Inc. researches and develops therapeutic products. It is using nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize drug-delivery-enhanced small-molecule therapeutics and nucleic acids. Cyclosert uses cyclodextrins as building blocks to create biocompatible materials - linear cyclodextrin-containing polymers that are non-toxic and non-immunogenic at therapeutic doses. The company was founded in February 2000 by Mark Davis and is located in Pasadena, CA | Präsident | 16.09.2006 |
| The Alfred E. Mann Foundation For Scientific Research | Vorstandsvorsitzender | - |
Ausbildung von John George Petrovich
| University of Southern California | Undergraduate Degree |
| University of California, Los Angeles | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| AXONICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Insert Therapeutics, Inc.
Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Insert Therapeutics, Inc. researches and develops therapeutic products. It is using nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize drug-delivery-enhanced small-molecule therapeutics and nucleic acids. Cyclosert uses cyclodextrins as building blocks to create biocompatible materials - linear cyclodextrin-containing polymers that are non-toxic and non-immunogenic at therapeutic doses. The company was founded in February 2000 by Mark Davis and is located in Pasadena, CA | Commercial Services |
| The Alfred E. Mann Foundation For Scientific Research | Miscellaneous |
| Medallion Therapeutics, Inc. |